Download this poster to share. The REDOSE 2.0 study aims to better understand the concentrations and side effects of bictegravir, a commonly prescribed antiretroviral medication. This medication is part of a regimen called Biktarvy. Participation in this study is voluntary and you can withdraw at any time. All information collected will remain confidential. You… Read more »
ReEvaluating antiretroviral Drug cOncentrations and Side Effects in individuals living with HIV
Posted On: Thursday, April 10th, 2025